Lydia Laboccetta, Urology Medicare: Accepting Medicare Assignments Practice Location: 584 Hospital Dr Ne Unit D, Bolivia, NC 28422 Phone: 910-721-4150 Fax: 910-721-4159 |
Steven Eric Robbins, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 584 Hospital Dr Ne Unit D, Bolivia, NC 28422 Phone: 910-721-4150 Fax: 910-721-4159 |
News Archive
The public is invited to a free web interview with Dr. Susan Barry, neuroscientist, professor and author of Fixing My Gaze. Dr. Barry, recently interviewed by Terry Gross on NPR's Fresh Air program, is famous for gaining 3D vision as an adult and sharing her experiences in her book, which was just released in paperback.
Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer. The Chronix tests detect the circulating DNA that is released into the blood stream by damaged and dying cells. A growing body of publications from Chronix and other researchers shows that this circulating DNA can be identified and analyzed to provide a diagnostic window into ongoing changes in the genome associated with specific diseases—changes that can be used to identify disease processes at an early stage and to track responses to treatment.
Whitehead researchers have developed a new type of genetic screen for human cells to pinpoint specific genes and proteins used by pathogens, according to their paper in Science.
Prescribing both a stimulant and an antipsychotic drug to children with physical aggression and attention-deficit/hyperactivity disorder (ADHD), along with teaching parents to use behavior management techniques, reduces aggressive and serious behavioral problems in children, according to a study conducted by researchers in the Department of Psychiatry at Stony Brook University School of Medicine.
Minneapolis Star Tribune, on the Biotechnology Industry Organization's convention in Chicago: "The biotechnology industry, hurt by the recession, is looking for inspiration from Charles Darwin. Leading executives say unless biotech companies adapt to a less-robust economy and changing industry standards, they won't survive the downturn. Biotech start-ups, seen as the lifeblood of the industry, have been among the worst hit by a decline in venture capital investments."
› Verified 2 days ago